Section 32 targets $350 million for third fund
The VC firm, started by the former heads of Foundation Medicine and Google Ventures, is raising $350 million for its third fund, according to a filing with the Securities and Exchange Commission.
Deerfield Management to spend $635M on New York life sciences hub
The healthcare investment management firm is working with the city's nonprofit economic development corporation and Chicago-based MATTER on the new project, which will focus on life sciences and digital health.
The Power of One: Redefining Healthcare with an AI-Driven Unified Platform
In a landscape where complexity has long been the norm, the power of one lies not just in unification, but in intelligence and automation.
Alexandria to pay $143.5M to develop new Seattle life sciences campus
Under the deal, which awaits city council approval, illustrates Seattle's rapid growth as a life sciences hub, in addition to its larger IT sector. The nearly 3-acre parcel sits in a rapidly growing neighborhood that is also home to Amazon.
Medicxi closes fund worth nearly $449 million, aims for investments in platforms, pipelines
While it trails its U.S. counterpart, Europe's life science sector has seen an increase in interest from investors lately. A report released Thursday by Silicon Valley Bank indicates growing investment in European biopharma and diagnostics.
Health unicorns’ valuations often outweigh their body of peer-reviewed research, study finds
Peer review is important for ensuring transparency and trust and may have put a stop to Theranos before it became a darling of investors and the press, the lead study author said in an interview.
Report sees strong year ahead for life sciences IPOs despite headwinds
The report, by law firm WSGR, noted an almost twofold increase in life sciences IPOs - especially biotech - and a greater number priced at $250 million or more.
presented by
Enhanced Direct Enrollment: Georgia Access and the Power of Partnership
Across the nation, state-based health insurance exchanges are searching for ways to better serve their communities while making enrollment easier, more personal, and more accessible for everyone.
Survey: UK life sciences face post-Brexit apocalypse; but expert sees more shades of grey
A number of scenarios could indeed diminish the UK's attractiveness, but it is likely to remain an important player, with a lot riding on the future regulatory regime.
Life sciences VC investment trends similar to tech, but there are differences
Deals worth $50 million or more are becoming more frequent, even in Series A. But a VC investor said underlying drivers in life sciences are different from the technology sector.
R&D veterans launch $320M life sciences VC firm in Los Angeles
With $320 million on hand to invest in life sciences startups, Westlake Village BioPartners will tap its founders' biotechnology expertise.
TraceLink raises $93 million in Series D financing round
The company's life sciences track-and-trace network reaches drugmakers, pharmacies and others, with a customer base of more than 930 companies.
presented by
MedCity News Pivot Podcast: How Emergency Departments Are Using Real-Time Data to Improve Outcomes
How can AI benefit and improve patient outcome in the emergency department? Watch the latest episode to find out.
The M&A landscape for life sciences companies
McDermott Will & Emery partner Kristian Werling is co-chair of the firm’s robust Life Sciences practice. According to Krist, McDermott’s Life Sciences group has “all the tools in the toolkit to help life science entrepreneurs, growth-stage companies and large global companies achieve their patient-centered mission. Hearing patients, helping heal patients and everything in between.” About […]
The 10 Most Innovative Life Sciences Deals Of 2017
These transactions best exemplify the most significant trends in the life sciences and biotech space.
Life Sciences Law Firm Index: Top Deal Firms Update
One year ago, in collaboration with Lake Whillans and our sister site MedCity News, we launched the inaugural Life Sciences Law Firm Index to recognize law firms that are the most active and relevant for life science companies. Over the course of 2016, we have published updates to the Index, each focusing on a different practice area. Today, […]
Research and Development: Bridging the Gap Between Hospitals, Patients, and Life Sciences
We live in a golden age of medicine. Never before have so many effective treatment options been available to so many people. And precision medicine is bringing new horizons, as well as the promise to further improve disease prevention, treatment, and ultimately find more cures. To keep moving toward personalized medicine approaches, more individuals would […]
This week on MedHeads: Talk of what Google really brings to the table in healthcare innovation
This week we will take a closer look at how players like Alphabet (Google in general) are really making an impact in healthcare innovation. Does it look promising?